AJANTA PHARMA LTD. - Investor Presentation

We refer to the Unaudited financial results for the second quarter and half year ended 30th September, 2017 submitted to your office today.<BR> <BR> Pursuant to Regulation 46 SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are now attaching the presentation on results being circulated to the investors and analysts and uploaded on our website.<BR> <BR> Kindly take the same on your records and disseminate to your members.<BR>